论文部分内容阅读
目的探究他达拉非每日一次给药对中老年男性勃起功能障碍(ED)患者血清睾酮水平的影响。方法选择2014年8月-2016年8月深圳市龙岗区人民医院收治的40例中老年男性ED患者,随机分为观察组和对照组各20例,观察组给予他达拉非每日一次给药治疗(他达拉非,5 mg/d,口服),对照组给予他达拉非按需服用20 mg治疗。对比两组治疗效果。结果观察组治疗后IIEF-5评分为(20.71±3.92)分,SEP评分为(4.04±1.07)分,均高于对照组的(18.51±4.14)分、(3.42±1.09)分;观察组治疗后FT为(0.39±0.06)nmol/L,TT为(15.42±3.24)nmol/L,均高于对照组的(0.21±0.05)nmol/L、(10.26±1.21)nmol/L;观察组治疗后性生活满意度为85.0%,高于对照组的55.0%;差异均有统计学意义(P<0.05)。结论采用他达拉非每日一次给药治疗中老年男性ED患者,可有效改善血清睾酮水平,提高性生活质量,疗效确切,值得临床推广应用。
Objective To investigate the effect of once-daily administration of tadalafil on serum testosterone in middle-aged and elderly men with erectile dysfunction (ED). Methods Forty middle-aged and elderly male ED patients admitted from Longgang District People’s Hospital from August 2014 to August 2016 were randomly divided into observation group (20 cases) and control group (20 cases). The observation group was given tadalafil once daily Drug treatment (tadalafil, 5 mg / d, orally), the control group was given tadalafil on-demand 20 mg treatment. Compare the two groups treatment effect. Results After treatment, the score of IIEF-5 in the observation group was (20.71 ± 3.92) points and the SEP score was (4.04 ± 1.07) points higher than that in the control group (18.51 ± 4.14 points and (3.42 ± 1.09) points respectively) FT was (0.39 ± 0.06) nmol / L and TT was (15.42 ± 3.24) nmol / L, both higher than that of the control group (0.21 ± 0.05 nmol / L, 10.26 ± 1.21 nmol / L) The post-sex life satisfaction was 85.0%, which was higher than that of the control group (55.0%). The differences were statistically significant (P <0.05). Conclusion Tadalafil once daily treatment of ED patients with middle-aged and elderly men, can effectively improve serum testosterone levels, improve sexual quality of life, the exact effect, worthy of clinical promotion and application.